HK$8.15
1.87%
Hong Kong, Sep 18, 04:00 pm HKT. Closed.
ISIN
KYG2110P1000
Symbol
2877

China Shineway Pharmaceutica Stock price

HK$8.13
+0.07 0.81% 1M
-1.00 10.91% 6M
-0.48 5.52% YTD
-0.32 3.73% 1Y
+0.94 13.00% 3Y
+0.42 5.38% 5Y
+0.24 3.08% 10Y
+3.85 90.16% 20Y
Hong Kong, Closing price Fri, Sep 18 2026
-0.18 2.11%
ISIN
KYG2110P1000
Symbol
2877
Industry

Is China Shineway Pharmaceutica a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$6.3b
Enterprise Value
HK$-2.2b
Net debt
positive
Cash
HK$8.8b
Shares outstanding
827.0m
Valuation (TTM | estimate)
P/E
6.5
P/S
2.0 | 2.2
EV/Sales
negative | negative
EV/FCF
-
P/B
0.7
Dividends
DPS
HK$0.51
Yield 1Y | 5Y
6.2% | 7.0%
Growth 1Y | 5Y
-13.1% | 14.7%
Payout 1Y | 3Y
34.4% | 36.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HK$3.1b | HK$2.8b
EBITDA
-
EBIT
HK$946.9m
Net Income
HK$942.0m
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-20.3% | -23.7%
EBITDA
-
EBIT
-0.8%
Net Income
-2.9%
Free Cash Flow
-
Margin
Gross
71.3%
EBITDA
-
EBIT
30.4%
Net
30.2%
Free Cash Flow
-
Financial Health
Equity Ratio
74.8%
Return on Equity
11.8%
ROCE
9.7%
ROIC
53.6%
Debt/Equity
0.0
More
EPS
HK$1.3
FCF per Share
-
Short interest
-
Employees
3k
Rev per Employee
HK$1.3m

China Shineway Pharmaceutica Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a China Shineway Pharmaceutica forecast:

3x Hold
33%
6x Sell
67%

Analyst Opinions

9 Analysts have issued a China Shineway Pharmaceutica forecast:

Hold
33%
Sell
67%

Financial data from China Shineway Pharmaceutica

Jun '26
+/-
%
3,119 3,119
20% 20%
100%
- Direct Costs 896 896
14% 14%
29%
2,223 2,223
23% 23%
71%
- Selling and Administrative Expenses 1,320 1,320
34% 34%
42%
- Research and Development Expense 140 140
13% 13%
4%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 947 947
1% 1%
30%
Net Profit 942 942
3% 3%
30%

In millions HKD.

Don't miss a Thing! We will send you all news about China Shineway Pharmaceutica directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.

Head office Cayman Islands
Employees 2,822
Website www.shineway.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today